JPMorgan prices DexCom-linked auto-callable notes
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
JPMorgan Chase Financial Company LLC is offering $2,009,000 Auto Callable Contingent Interest Notes linked to the common stock of DexCom, Inc., due July 13, 2028, fully and unconditionally guaranteed by JPMorgan Chase & Co.
The notes pay a 12.35% per annum contingent coupon (3.0875% per quarter) for each Review Date on which DexCom’s closing price is at or above the Interest Barrier of 50.00% of the Initial Value. The Initial Value is $73.02, so the Interest Barrier and Trigger Value are $36.51. If on any non-first, non-final Review Date DexCom closes at or above the Initial Value, the notes are automatically called for $1,000 plus that quarter’s interest.
If not called and the Final Value is at or above the Trigger Value, investors receive $1,000 plus the final contingent interest; if below, repayment falls to $1,000 × Final Value/Initial Value, exposing principal to losses beyond 50% and potentially to a total loss. The notes are unsecured obligations subject to the credit risk of JPMorgan Financial and JPMorgan Chase & Co. The estimated value is $962.50 per $1,000 note, below the $1,000 issue price due to selling commissions, structuring fees and hedging costs. The notes are not listed; secondary liquidity, if any, would depend on JPMS.
Key Figures
Key Terms
Contingent Interest Payment financial
Trigger Value financial
Stock Adjustment Factor financial
acceleration event financial
internal funding rate financial
Section 871(m) financial
Offering Details
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What security is JPM (JPMorgan) offering in this 424B2 pricing supplement?
How do the contingent interest payments on the JPM DexCom-linked notes work?
When are the JPM DexCom-linked notes automatically called?
What principal risk do investors in JPM’s DexCom-linked notes face at maturity?
What is the estimated value versus the issue price of JPM’s DexCom-linked notes?
Are JPM’s DexCom-linked notes liquid or exchange-listed?
How are the JPM DexCom-linked notes expected to be treated for U.S. federal tax purposes?
AI-generated analysis. How Rhea-AI works. Not financial advice.